daraxonrasib

A Landmark Breakthrough in Oncology: FDA Approval of Daraxonrasib Marks a New Era for Pancreatic Cancer Treatment

In a monumental shift for oncology, the U.S. Food and Drug Administration (FDA) recently granted approval for daraxonrasib, a breakthrough…